Amneal Pharmaceuticals, Inc. Stock News

SVB Leerink analyst Ami Fadia says the pandemic could bring some relief to beaten-down generic-drug companies.

The New York Times, in a major article, says Trump has a “small personal stake” in Sanofi, the French drugmaker that produces the drug. Here’s how small.

Amneal Pharmaceuticals Inc (NYSE:AMRX) traded up 9.4% on Monday . The company traded as high as $3.16 and last traded at $3.14, 1,525,343 shares traded hands during trading. A decline of 19% from the

States across the U.S. are instituting measures to prevent hoarding of malaria drugs hydroxychloroquine and chloroquine in an effort to maintain supply amid acute demand from pharmacies and COVID-19 p

Great West Life Assurance Co. Can purchased a new stake in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) in the 4th quarter, Holdings Channel reports. The fund purchased 7,150 shares of the company

Amalgamated Bank lifted its position in Amneal Pharmaceuticals Inc (NYSE:AMRX) by 19.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange

Equities research analysts forecast that Amneal Pharmaceuticals Inc (NYSE:AMRX) will announce $439.11 million in sales for the current quarter, according to Zacks. Five analysts have issued estimates

Regulators take different approaches to the unapproved medications.

In a report released today, David Risinger from Morgan Stanley maintained a Hold rating on Amneal Pharmaceuticals ( AMRX – Research Report ), with a price target of $3.00 . The company’s shares cl

The FDA is requesting all manufacturers of ranitidine drugs to withdraw them immediately from the U.S. market due to the presence of an impurity called N-Nitrosodimethylamine (NDMA), a suspect

In a note, UBS regards the republished results from one of the first randomized trials evaluating malaria drug hydroxychloroquine (HCQ) in COVID-19 patients as "inconclusive."62 patien

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Danaher (DHR), Amneal Pharmaceuticals (AMRX) and CytomX

Plus Therapeutics. (NASDAQ:PSTV) +63% in-licenses novel oncology candidates.Bellerophon Therapeutics (NASDAQ:BLPH) +40% as first COVID-19 patient has been treated with the INOpulse inhaled nitric o

The short- and long-term outlook is good, but mid-term risks are high. Here's what you can do now. Top sectors and stocks you ought to be considering for portfo

Blueshift Asset Management LLC raised its holdings in Amneal Pharmaceuticals Inc (NYSE:AMRX) by 35.1% during the fourth quarter, Holdings Channel.com reports. The fund owned 66,564 shares of the compa